[
  {
    "ts": "2025-11-13T12:00:17+00:00",
    "headline": "Are Investors Undervaluing The Kroger Co. (NYSE:KR) By 25%?",
    "summary": "Key Insights Using the 2 Stage Free Cash Flow to Equity, Kroger fair value estimate is US$87.44 Kroger's US$65.40 share...",
    "url": "https://finance.yahoo.com/news/investors-undervaluing-kroger-co-nyse-120017876.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "e251c675-7c04-36d8-8505-a534923782bb",
      "content": {
        "id": "e251c675-7c04-36d8-8505-a534923782bb",
        "contentType": "STORY",
        "title": "Are Investors Undervaluing The Kroger Co. (NYSE:KR) By 25%?",
        "description": "",
        "summary": "Key Insights Using the 2 Stage Free Cash Flow to Equity, Kroger fair value estimate is US$87.44 Kroger's US$65.40 share...",
        "pubDate": "2025-11-13T12:00:17Z",
        "displayTime": "2025-11-13T12:00:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/3d17282617dddc4b711d8151bca35d83",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZSoklwv9hM_ICpZEwDDQtg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3d17282617dddc4b711d8151bca35d83.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9YnV5w_lJXxud87R0O3New--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/3d17282617dddc4b711d8151bca35d83.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investors-undervaluing-kroger-co-nyse-120017876.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-undervaluing-kroger-co-nyse-120017876.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T13:00:00+00:00",
    "headline": "Synergy CHC Corp. Reports Third Quarter 2025 Financial Results and its Eleventh Consecutive Quarter of Profitability",
    "summary": "WESTBROOK, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, is announcing its financial results for the three months ended September 30, 2025. “We are pleased to report our 11th quarter of profitability and double-digit revenue growth, accompanied by over 300 basis points of gross margin expansion,” said Jack Ross, CEO of Synergy CHC Corp. “We made meaningful progress across our strategic prior",
    "url": "https://finance.yahoo.com/news/synergy-chc-corp-reports-third-130000225.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "37ddb045-0a38-356c-ae0a-54168ee9e5fc",
      "content": {
        "id": "37ddb045-0a38-356c-ae0a-54168ee9e5fc",
        "contentType": "STORY",
        "title": "Synergy CHC Corp. Reports Third Quarter 2025 Financial Results and its Eleventh Consecutive Quarter of Profitability",
        "description": "",
        "summary": "WESTBROOK, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, is announcing its financial results for the three months ended September 30, 2025. “We are pleased to report our 11th quarter of profitability and double-digit revenue growth, accompanied by over 300 basis points of gross margin expansion,” said Jack Ross, CEO of Synergy CHC Corp. “We made meaningful progress across our strategic prior",
        "pubDate": "2025-11-13T13:00:00Z",
        "displayTime": "2025-11-13T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/8e2fd2e12bbb995062a6b9cf57644da8",
          "originalWidth": 294,
          "originalHeight": 62,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sokRGaAigHImBGSYnufjNg--~B/aD02Mjt3PTI5NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/8e2fd2e12bbb995062a6b9cf57644da8.cf.webp",
              "width": 294,
              "height": 62,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z1vxr2nfnnFQf7WL1wm3BA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8e2fd2e12bbb995062a6b9cf57644da8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/synergy-chc-corp-reports-third-130000225.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/synergy-chc-corp-reports-third-130000225.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SNYR"
            },
            {
              "symbol": "KR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T14:33:00+00:00",
    "headline": "Elon Musk bashes government for taxing the ‘daylight’ out of people. Here’s the #1 way to get rich and keep your cash",
    "summary": "Why building wealth is not just about how much you earn.",
    "url": "https://finance.yahoo.com/news/elon-musk-bashes-government-taxing-143300762.html",
    "source": "Moneywise",
    "provider": "yfinance",
    "raw": {
      "id": "e3700b5a-dc93-3c70-9063-3abcc6f0f737",
      "content": {
        "id": "e3700b5a-dc93-3c70-9063-3abcc6f0f737",
        "contentType": "STORY",
        "title": "Elon Musk bashes government for taxing the ‘daylight’ out of people. Here’s the #1 way to get rich and keep your cash",
        "description": "",
        "summary": "Why building wealth is not just about how much you earn.",
        "pubDate": "2025-11-13T14:33:00Z",
        "displayTime": "2025-11-13T14:33:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/moneywise_ecomm_711/a76a81eb44ba256754fc5ce976b728e5",
          "originalWidth": 728,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0lfYCENiovRHo1ngFfA3TA--~B/aD00MDA7dz03Mjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneywise_ecomm_711/a76a81eb44ba256754fc5ce976b728e5.cf.webp",
              "width": 728,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6h.S12LdgNN.zIOVKhgAQQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneywise_ecomm_711/a76a81eb44ba256754fc5ce976b728e5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Moneywise",
          "url": "https://moneywise.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/elon-musk-bashes-government-taxing-143300762.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/elon-musk-bashes-government-taxing-143300762.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "KR"
            },
            {
              "symbol": "WMT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T16:00:00+00:00",
    "headline": "Persephone Biosciences Announces Topline Results from AMBROSIA Food as Medicine Study with Kroger Health",
    "summary": "- AMBROSIA is the largest study to evaluate the impact of Medical Nutrition Therapy (MNT) on diet quality and the gut microbiome, with 546 participants enrolled - - Topline results from the study identified three enterotypes, one of which was associated with increased BMI and poorer diet, and demonstrated that MNT can successfully improve microbiome composition and enable patients to switch enterotypes - - The U.S.-based study was run in collaboration with Kroger Health, the healthcare division",
    "url": "https://finance.yahoo.com/news/persephone-biosciences-announces-topline-results-160000281.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "e2937116-448a-3876-a6ef-722e03f09c2e",
      "content": {
        "id": "e2937116-448a-3876-a6ef-722e03f09c2e",
        "contentType": "STORY",
        "title": "Persephone Biosciences Announces Topline Results from AMBROSIA Food as Medicine Study with Kroger Health",
        "description": "",
        "summary": "- AMBROSIA is the largest study to evaluate the impact of Medical Nutrition Therapy (MNT) on diet quality and the gut microbiome, with 546 participants enrolled - - Topline results from the study identified three enterotypes, one of which was associated with increased BMI and poorer diet, and demonstrated that MNT can successfully improve microbiome composition and enable patients to switch enterotypes - - The U.S.-based study was run in collaboration with Kroger Health, the healthcare division",
        "pubDate": "2025-11-13T16:00:00Z",
        "displayTime": "2025-11-13T16:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/c9636de6c8ec327183acc0bf65671f7b",
          "originalWidth": 3833,
          "originalHeight": 967,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oTf6a1rwauiSFLpvdNkb4w--~B/aD05Njc7dz0zODMzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c9636de6c8ec327183acc0bf65671f7b.cf.webp",
              "width": 3833,
              "height": 967,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jSYtBjZPiTazsE05UB1vyA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c9636de6c8ec327183acc0bf65671f7b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/persephone-biosciences-announces-topline-results-160000281.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/persephone-biosciences-announces-topline-results-160000281.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]